Bridge Neurotech Emerges from Stealth with Non-Invasive Brain-Computer Interface Vision, Partners with Butterfly Network Bridge Neurotech, a company developing a completely non-invasive brain-computer interface (BCI), has emerged from stealth with…
RoslinCT Secures Up to £7.25 Million Scottish Enterprise Grant to Accelerate Digital Transformation of Cell Therapy Manufacturing RoslinCT, a global Contract Development and Manufacturing Organization (CDMO) specializing in advanced cell…
Invivoscribe Launches Complete LymphoTrack Flex Suite for NGS-Based Clonality and MRD Analysis Invivoscribe, a global provider of precision diagnostics and measurable residual disease (MRD) testing solutions, has announced the launch…
Dexcom Launches Fifth Season of Dexcom U NIL Program for College Athletes With Diabetes Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, has launched the fifth season of…
City of Hope Names Laurie Sicaeros and Melissa Childress to Lead Cancer Centers in Arizona and Atlanta City of Hope, one of the largest and most advanced cancer research and…
Nitto Avecia’s Milford Facility Receives FDA No Action Indicated Classification Following cGMP Inspection Nitto Avecia, a contract development and manufacturing organization (CDMO) specializing in oligonucleotide therapeutics, announced that the U.S.…
Shape Memory Medical Receives ANVISA Authorization for IMPEDE Embolization Plug Portfolio in Brazil Shape Memory Medical Inc., a medical technology company developing volume-expanding shape memory polymer solutions for endovascular embolization,…
NeuroLife Appoints Christopher Coburn and Matthew Thomas to Board as Company Advances Neurotechnology Platform Appoints®, a neurotechnology company focused on developing non-invasive solutions to help restore function and independence for…
Exthymic Receives Up to $25 Million ARPA-H Award to Advance LITTLESTAR Cell Therapy Manufacturing Device Exthymic Corporation, a biotechnology company developing technologies designed to expand access to engineered cell therapies,…
GE HealthCare to Acquire SOFIE Biosciences for $945 Million to Expand U.S. Radiopharmaceutical Manufacturing GE HealthCare (Nasdaq: GEHC) has announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based…
Epicrispr Reports Six-Month Clinical Data for EPI-321 Gene Therapy in FSHD Epicrispr Biotechnologies, a clinical-stage biotechnology company developing epigenetic therapies, has announced updated six-month clinical data from the ongoing first-in-human…
BioCentury Opens Registration for 2027 Grand Rounds Conference in Houston BioCentury has announced that registration is now open for the sixth edition of BioCentury Grand Rounds: US, a translational science-focused…